Series B - Apollo Therapeutics - 2021-06-17 - Crunchbase

Jun 17, 2021 · Apollo Therapeutics raised $139380010 on 2021-06-17 in Series B. Patient Square Capital Patient Square Capital is a health care investment firm that will make investments by …

CouponFollow Extension

$139380010
OFF

Series B - Apollo Therapeutics - 2021-06-17 - Crunchbase

4 weeks from now

Jun 17, 2021 · Apollo Therapeutics raised $139380010 on 2021-06-17 in Series B. Patient Square Capital Patient Square Capital is a health care investment firm that will make investments by …

crunchbase.com

$145
OFF

Fierce Biotech Fundraising Tracker '23

4 weeks from now

Dec 20, 2023 · The latest financing round—which follows a $145 million series B in 2021—will also help Apollo license or acquire more clinical-stage programs of interest. The company has …

fiercebiotech.com

$260
OFF

Apollo Therapeutics - Crunchbase Company Profile & Funding

4 weeks from now

Apollo Therapeutics may be growing as evidenced by the successful second close of its Series C financing, which brought the total raised in the round to $260 million. This substantial capital …

crunchbase.com

$405
OFF

Apollo Therapeutics Company Profile 2024: Valuation, Funding ...

4 weeks from now

Apollo Therapeutics has raised $405M. Who are Apollo Therapeutics’s investors? Hemma Group (Zurich) , M&G , AlbionVC , Patient Square Capital , and Reimagined Ventures are 5 of 14 …

pitchbook.com

$226
OFF

Apollo Takes Off With $226M Series C - Fierce Biotech

4 weeks from now

Sep 6, 2023 · The latest financing round—which follows a $145 million series B in 2021—was commanded by Patient Square Capital and included participation by M&G plc, Rock Springs …

fiercebiotech.com

$455
OFF

Apollo Therapeutics Stock Price, Funding, Valuation, Revenue ...

4 weeks from now

Dec 1, 2023 · Funding, Valuation & Revenue. 4 Fundings. Apollo Therapeutics has raised $455M over 4 rounds.. Apollo Therapeutics's latest funding round was a Series C - II for $33.5M on …

cbinsights.com

$32
OFF

Global Biotech VC Trends In Q1 2024 - Drug Discovery And …

4 weeks from now

Apr 5, 2024 · Notable companies in this category include Aqemia, which raised $32.5 million in a Series A round for its quantum and statistical mechanics algorithms for drug discovery, and …

drugdiscoverytrends.com

$226
OFF

Apollo Therapeutics Closes $226.5 Million Series C Financing Led …

4 weeks from now

Sep 6, 2023 · CAMBRIDGE, UK & BOSTON, US – SEPTEMBER 6, 2023 – Apollo Therapeutics (“Apollo” or “the Company”), a portfolio biopharmaceutical company focused on translating …

apollotx.com

$224972159
OFF

Series C - Apollo Therapeutics - 2023-09-06 - Crunchbase

4 weeks from now

Sep 7, 2023 · Apollo Therapeutics raised $224972159 on 2023-09-06 in Series C. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …

crunchbase.com

$32000000
OFF

Series B - Apollo.io - 2021-11-01 - Crunchbase

4 weeks from now

Nov 1, 2021 · Apollo.io raised $32000000 on 2021-11-01 in Series B. Tribe Capital Tribe Capital is a venture capital firm that focuses on capturing a perpetual edge in venture and crypto using …

crunchbase.com

$100000000
OFF

Series B - Scribe Therapeutics - 2021-03-31 - Crunchbase

4 weeks from now

Mar 31, 2021 · Scribe Therapeutics raised $100000000 on 2021-03-31 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... News — Scribe Therapeutics Raises …

crunchbase.com

$270
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Goes

4 weeks from now

Apr 28, 2023 · The startup closed a $270 million Series A led by Arch Venture Partners. Orbital is looking to expand RNA-based medicines including next-generation vaccines, …

crunchbase.com

$265000000
OFF

Series B - Sonoma BioTherapeutics - 2021-08-04 - Crunchbase

4 weeks from now

Aug 4, 2021 · Sonoma BioTherapeutics raised $265000000 on 2021-08-04 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... sonomabio.com — Sonoma …

crunchbase.com

FAQs about Series B - Apollo Therapeutics - 2021-06-17 - Crunchbase Coupon?

Who are Apollo Therapeutics investors?

September 6—Apollo Therapeutics Investors: Patient Square Capital, M&G plc, Rock Springs Capital and two unnamed U.S. public pension plans. Apollo Therapeutics' whopping series C will bolster its hub-and-spoke approach to drug development encompassing 20-plus pipeline programs that remain largely under wraps. ...

Where is apollotherapeutics based?

Backed by leading specialist health care investors, Apollo has operations in Cambridge, U.K., and Boston and Chicago, U.S. Apollo has raised a total of over $450m since its inception. For more information, visit www.apollotherapeutics.com. About Patient Square Capital ...

Are investors backing fewer Series B deals in 2023?

So far in 2023, Crunchbase data shows investors are backing fewer big rounds. There were just six Series B deals of $100 million or more to date this year, an average of fewer than one per week. In 2022, by comparison, there were 90 such rounds, or almost two per week. Still, we are seeing some mega-sized Series B deals this year. ...

What happened to Series B funding in 2023?

In recent months, Series B funding to U.S. startups has fallen sharply. So far in 2023, investment is on track to come in at the lowest quarterly level in more than three years. Search less. Close more. Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data. ...

Who are orbital Therapeutics investors?

April 26—Orbital Therapeutics Investors: ARCH Venture Partners, a16z, Newpath Partners, Abu Dhabi Growth Fund, Redmile Group, Exor N.V., Invus, Moore Strategic Ventures, iGlobe Platinum Fund Group, Casdin Capital, Agent Capital, Alexandria Venture Investments, Rellim Capital Management, Heritage Medical Systems and other undisclosed investors. ...

Is Series B funding still a good investment?

When technology and biotech valuations began to tumble last year, U.S. Series B funding held up at first, offering one of the brighter areas in a more bearish investment environment. That’s no longer the case. In recent months, Series B funding to U.S. startups has fallen sharply. ...